Clinical Trial Update: Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. [Phase 3]

View source ↗

Summary

A Phase 3 immunogenicity and safety study of an infant meningitis vaccine given after a hepatitis B birth dose completed; the trial evaluated immune response an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Meningitis
• Pertussis
• Tetanus

Drugs mentioned

• Infant meningitis vaccine (post-hepatitis B birth dose)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Hepatitis B | Phase 3 | Status: COMPLETED